WEB W5-7-S-MVI-3Recalls & reported problems
Microvention, Inc. · WEB 17 SLS 7 · Class 3 · Implant
All models of WEB (14)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00842429110966), received between Mar 28, 2025 and Mar 28, 2025 — classified as 1 injury.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).
1 other recall cover devices cleared under the same FDA submission (P170032); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Dislodged or Dislocated1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMar 28, 2025Device Dislodged or Dislocated; Device Dislodged or Dislocated
AS REPORTED THROUGH THE WEB PAS CLINICAL STUDY: WEB IMPINGEMENT INTO PARENT VESSEL. "A 7MM WEB SLS DEVICE INSIDE THE ANEURYSM SAC. A CONTRAST INJECTION AFTER INITIAL DEPLOYMENT SHOWED COMPLETE OCCLUSION OF THE ANEURYSM WITH MILD ENCROACHMENT ONTO THE PARENT ARTERY (SERIES 4). GIVEN THIS, WE PROCEEDED TO DETACH THIS DEVICE. A POST-DETACHMENT CONTRAST INJECTION SHOWED THAT THE PROXIMAL ASPECT OF THE WEB DEVICE HAD HERNIATED PROXIMALLY AND NOW COVERED THE RIGHT M2 SEGMENT, WITH APPROXIMATELY 90% PROTRUSION (SERIES 5). GIVEN THIS FINDINGS, WE PROCEEDED TO MANIPULATE THE WEB DEVICE WITH THE [ ] MICROWIRE, IN AN ATTEMPT TO GET MORE BRAIN INSIDE THE ANEURYSM. A REPEAT CONTRAST INJECTION AFTER THIS MANEUVER SHOWED THAT THERE WAS LESS PROTRUSION ONTO THE M2 SEGMENT (80%, SERIES 6). AT THIS JUNCTURE, WE REMOVED THE [ ] MICROCATHETER FROM THE CIRCULATION AND PROCEEDED TO ADMINISTERED A 40MG PROTAMINE BOLUS TO REVERSE THE HEPARIN ADMINISTERED. AFTER A 5 MINUTE WAITING PERIOD, A REPEAT ANGIOGRAM DEMONSTRATED NO MOVEMENT OF THE WEB DEVICE AND FLOW THROUGH THE BRAIN TO SUPPLY THE M2 BRANCH WITH 80% PARENT ARTERY PROTRUSION (SERIES 7)." TREATMENT FOR THE ¿WEB IMPINGEMENT INTO PARENT VESSEL¿ WAS MA
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21719776 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P170032. One submission often covers many models, so check the product and lot details in each record.
- Z-0170-2023 · Sep 21, 2022 · Open, ClassifiedWEB Detachment Controller, REF: WDC-2, WDC, MV-WDC2. Component of WEB Aneurysm Embolization System.
Other Intrasaccular Flow Disruption Device devices
- WEB Detachment Controller WDC-2-MVIMicrovention, Inc. · Intrasaccular Flow Disruption Device1 recall0 reports
- WEB W5-4-2-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device1 death23 reports
- WEB 17 SL 6x2 W5-6-2-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device1 death20 reports
- WEB W5-5-2-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device20 reports
- WEB W5-4.5-2-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device19 reports
- WEB W5-7-3-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device1 death16 reports
- WEB W5-6-3-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device1 death15 reports
- WEB W5-5-3-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device14 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page